Fluorescence detection of malignant liver tumors using 5-aminolevulinic acid-mediated photodynamic diagnosis

Fluorescence detection of malignant liver tumors using 5-aminolevulinic acid-mediated photodynamic diagnosis - Fluorescence detection using 5-ALA

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013181

Enrollment

100

Registered

2014-02-17

Start date

2013-03-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant tumors

Interventions

Administration of 5-aminolevulinic acid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients with malignant tumors

Exclusion criteria

Exclusion criteria: the patient with porphilia

Design outcomes

Primary

Measure	Time frame
The detection of malignant tumor using 5-ALA fluorescent imaging	—

Secondary

Measure	Time frame
The detection of intra-operative bile leakage	—

Countries

Japan

Contacts

Public ContactYoshihiro Inoue

Osaka Medical College Hospital Departments of General and Gastroenterological Surgery

sur129@poh.osaka-med.ac.jp072-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026